F. Sperati

发表

Using alternative statistical formats for presenting risks and risk reductions.

E. Akl, A. Oxman, H. Schünemann, 2011, The Cochrane database of systematic reviews.

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

G. Ciliberto, E. Gallo, B. Casini, 2018, Journal of Translational Medicine.

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy

Francesca Sperati, Ruggero De Maria, M. T. Ramieri, 2017, Cancer biology & therapy.

Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer

V. Speirs, M. Mottolese, A. Shaaban, 2017, Journal of cellular physiology.

HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes

V. Speirs, M. Mottolese, A. Shaaban, 2016, Scientific Reports.

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer

M. Rinaldi, A. Giordano, P. Marchetti, 2018, Journal of cellular physiology.

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas

G. Piaggio, M. Rizzo, I. Terrenato, 2016, Journal of experimental & clinical cancer research : CR.

Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast‐enhanced MRI of soft tissue tumors

F. Sperati, S. Marzi, L. Stefanetti, 2016, NMR in biomedicine.

Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study

F. Sperati, D. Orsini, A. Morrone, 2021, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy

P. Muti, M. Maschio, L. Dinapoli, 2010, Journal of Neuro-Oncology.

Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis

Li Yang, H. Schünemann, P. Muti, 2009, Journal of experimental & clinical cancer research : CR.

Multiparametric MRI Evaluation of Oropharyngeal Squamous Cell Carcinoma. A Mono-Institutional Study

G. Sanguineti, L. Marucci, R. Covello, 2021, Journal of clinical medicine.

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2018, The Cochrane database of systematic reviews.

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2018, The Cochrane database of systematic reviews.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2014, The Cochrane database of systematic reviews.

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

E. Akl, H. Schünemann, P. Muti, 2008, Journal of experimental & clinical cancer research : CR.

Parenteral anticoagulation in ambulatory patients with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2017, The Cochrane database of systematic reviews.

Anticoagulation for patients with cancer and central venous catheters.

D. Cook, E. Akl, H. Schünemann, 2011, The Cochrane database of systematic reviews.

Thromboprophylaxis for patients with cancer and central venous catheters

D. Cook, E. Akl, H. Schünemann, 2008, Cancer.

Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.

D. Cook, E. Akl, H. Schünemann, 2007, The Cochrane database of systematic reviews.

Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort

F. Berrino, P. Muti, P. Razavi, 2013, Breast Cancer Research.

Lacosamide on background eeg activity in brain tumor‐related epilepsy patients: A case series study

M. Maschio, L. Dinapoli, F. Sperati, 2018, Brain and behavior.

The efficacy of balneotherapy, mud therapy and spa therapy in patients with osteoarthritis: an overview of reviews

G. Castellini, S. Gianola, F. Sperati, 2021, International Journal of Biometeorology.

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer

G. Ciliberto, E. Gallo, B. Casini, 2018, Journal of Translational Medicine.

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

G. Botti, G. D'aiuto, G. Botti, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Lara A. Kahale, E. Akl, H. Schünemann, 2021, The Cochrane database of systematic reviews.

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

I. Vitale, M. Mottolese, I. Terrenato, 2017, BMC Cancer.

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

L. Mariani, G. Sanguineti, I. Vitale, 2016, PloS one.

Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.

E. Akl, H. Schünemann, P. Muti, 2008, The Cochrane database of systematic reviews.

Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer

E. Akl, H. Schünemann, P. Muti, 2007 .

Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial

G. Cigliana, M. Caterino, A. Giordano, 2018, Journal of cellular physiology.

Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.

Lara A. Kahale, D. Cook, E. Akl, 2014, The Cochrane database of systematic reviews.

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Lara A. Kahale, E. Akl, H. Schünemann, 2014, The Cochrane database of systematic reviews.

Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.

D. Cook, E. Akl, H. Schünemann, 2011, The Cochrane database of systematic reviews.

Anticoagulation for patients with cancer and central venous catheters.

D. Cook, E. Akl, H. Schünemann, 2011, The Cochrane database of systematic reviews.

An instrument to assess quality of life in relation to nutrition: item generation, item reduction and initial validation

G. Guyatt, E. Akl, H. Schünemann, 2010, Health and quality of life outcomes.

Oral anticoagulation for prolonging survival in patients with cancer.

E. Akl, H. Schünemann, I. Terrenato, 2007, The Cochrane database of systematic reviews.

Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics

F. Sperati, M. Pontone, F. Pimpinelli, 2022, Frontiers in Medicine.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

E. Akl, H. Schünemann, P. Muti, 2011, The Cochrane database of systematic reviews.

Extended perioperative thromboprophylaxis in patients with cancer

E. Akl, H. Schünemann, P. Muti, 2008, Thrombosis and Haemostasis.

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.

E. Akl, H. Schünemann, P. Muti, 2011, The Cochrane database of systematic reviews.

Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review.

E. Akl, H. Schünemann, I. Terrenato, 2007, Journal of experimental & clinical cancer research : CR.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (Review)

E. Akl, H. Schünemann, P. Muti, 2018 .

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

E. Akl, H. Schünemann, I. Terrenato, 2011, The Cochrane database of systematic reviews.

The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study)

G. Ciliberto, R. Biagini, V. Ferraresi, 2022, Frontiers in Oncology.

Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life

P. Muti, M. Maschio, L. Dinapoli, 2012, Journal of Neuro-Oncology.

Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.

Elie A Akl, Holger J Schünemann, Francesca Sperati, 2008, Archives of internal medicine.

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

E. Akl, H. Schünemann, I. Terrenato, 2010, Cochrane Database of Systematic Reviews.

Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions

G. Sanguineti, L. Marucci, F. Sperati, 2022, Frontiers in Oncology.

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

G. Sanguineti, A. Giordano, P. Marchetti, 2017, Scientific Reports.

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study

N. Tinari, G. Ciliberto, F. Cappuzzo, 2022, Cancers.

Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma

L. Fattore, R. Mancini, G. Madonna, 2022, Theranostics.

Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs

F. Sperati, M. Pontone, F. Pimpinelli, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas

G. Piaggio, M. Rizzo, I. Terrenato, 2016, Journal of experimental & clinical cancer research : CR.

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab

A. Giordano, M. Mottolese, C. A. Iannuzzi, 2014, Oncotarget.

Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life

P. Muti, M. Maschio, L. Dinapoli, 2011, Journal of Neuro-Oncology.

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

I. Vitale, M. Mottolese, I. Terrenato, 2017, BMC Cancer.

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

I. Vitale, M. Mottolese, A. Fabi, 2015, Oncotarget.

Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer

G. D'aiuto, A. Giordano, M. Mottolese, 2015, Journal of cellular physiology.

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression

G. Ciliberto, V. Speirs, I. Vitale, 2017, Scientific Reports.

Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability

P. Muti, M. Maschio, L. Dinapoli, 2011, Journal of Neurology.

Anticoagulation for people with cancer and central venous catheters.

Lara A. Kahale, E. Akl, H. Schünemann, 2018, The Cochrane database of systematic reviews.

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.

M. Filetti, G. Ciliberto, A. Vecchione, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Mutations in the KEAP1-NFE2L2 pathway define a molecular subset of rapidly progressing lung adenocarcinoma.

G. Ciliberto, P. Visca, E. Gallo, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer

G. Ciliberto, E. Gallo, B. Casini, 2018, Oncogenesis.

Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51

M. Biffoni, C. Galassi, I. Vitale, 2021, Cell Death & Differentiation.

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

M. Helmer-Citterich, M. Biffoni, C. Galassi, 2021, Nature Immunology.

Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study.

H. Schünemann, P. Muti, M. Gallucci, 2008, Urology.

ATM kinase sustains HER2 tumorigenicity in breast cancer

M. Mottolese, G. Piaggio, I. Manni, 2014, Nature Communications.

Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer

G. Ciliberto, E. Gallo, B. Casini, 2020, Clinical and translational medicine.

The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer

V. Speirs, M. Mottolese, A. Shaaban, 2016, Oncotarget.

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2021, The Cochrane database of systematic reviews.

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Lara A. Kahale, E. Akl, H. Schünemann, 2021, The Cochrane database of systematic reviews.

Anticoagulation for perioperative thromboprophylaxis in people with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2018, The Cochrane database of systematic reviews.

Anticoagulation for people with cancer and central venous catheters.

Lara A. Kahale, D. Cook, E. Akl, 2014, The Cochrane database of systematic reviews.

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.

Lara A. Kahale, E. Akl, H. Schünemann, 2014, The Cochrane database of systematic reviews.

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

M. Mottolese, I. Terrenato, F. Sperati, 2016, Journal of experimental & clinical cancer research : CR.

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment

L. Mariani, G. Sanguineti, I. Vitale, 2016, Oncoimmunology.

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

R. Maria, M. Mottolese, A. Pagliuca, 2014, Oncotarget.

Efficacy of injecting hybrid cooperative complexes of hyaluronic acid for the treatment of vulvar lichen sclerosus: A preliminary study

F. Sperati, V. Garelli, E. Migliano, 2022, Journal of cosmetic dermatology.

Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes

M. Filetti, G. Ciliberto, A. Vecchione, 2020, Journal for ImmunoTherapy of Cancer.

KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy.

G. Ciliberto, F. Cappuzzo, A. Vecchione, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Coping Style in Glioma Patients and Their Caregiver: Evaluation During Disease Trajectory

I. Terrenato, F. Sperati, D. Benincasa, 2021, Frontiers in Neurology.

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

E. Pescarmona, A. Sapino, M. Mottolese, 2017, Journal of Experimental & Clinical Cancer Research.

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

M. Biffoni, M. Todaro, G. Stassi, 2014, Oncogene.

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

G. Ciliberto, M. Fanciulli, M. Milella, 2019, Journal of Translational Medicine.

Intravoxel incoherent motion diffusion-weighted imaging for oropharyngeal squamous cell carcinoma: Correlation with human papillomavirus Status.

G. Sanguineti, L. Marucci, E. Gangemi, 2019, European journal of radiology.

Weight of epilepsy in brain tumor patients

M. Maschio, L. Dinapoli, A. Fabi, 2014, Journal of Neuro-Oncology.

Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

L. Mariani, A. Giordano, M. Mottolese, 2013, PloS one.

CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells

Francesca Sperati, Francesca Corradi, Matteo Pallocca, 2017, Gut.

Phase II study of weekly carboplatin in pretreated adult malignant gliomas

M. Maschio, B. Casini, F. Cognetti, 2019, Journal of Neuro-Oncology.

Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study

P. Muti, M. Maschio, L. Dinapoli, 2009, Neurological Sciences.

The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta‐analysis

G. Guyatt, E. Akl, P. Muti, 2009, Clinical endocrinology.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

E. Akl, H. Schünemann, P. Muti, 2008, Cancer.

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients

A. Giordano, P. Marchetti, A. Amodio, 2016, Journal of Cancer.

The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression

G. Ciliberto, E. Gallo, B. Casini, 2018, Oncoimmunology.

DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first‐line chemotherapy

E. Gallo, B. Casini, E. Pescarmona, 2017, International journal of cancer.

Title : DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

Marcella, Casini, R. Maria, 2017 .

The Validity and Sensitivity to Change of the Spanish Self-Administered Version of the Chronic Respiratory Questionnaire (CRQ-SAS)

G. Guyatt, H. Schünemann, F. Sperati, 2011 .

[The validity and sensitivity to change of the Spanish self-administered version of the chronic respiratory questionnaire (CRQ-SAS)].

G. Guyatt, H. Schünemann, F. Sperati, 2011, Archivos de bronconeumologia.

Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes

G. Sanguineti, E. Gangemi, F. Sperati, 2020, PloS one.

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

A. Paradiso, A. Paradiso, M. Mottolese, 2013, Journal of Experimental & Clinical Cancer Research.

Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.

Lara A. Kahale, E. Akl, H. Schünemann, 2021, The Cochrane database of systematic reviews.

The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition

C. Galassi, I. Vitale, F. Sperati, 2021, Cancers.

Iodixanol vs iopromide in cancer patients: evidence from a randomized clinical trial

Pozzi, G. Cigliana, M. Caterino, 2017 .

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

E. Akl, H. Schünemann, P. Muti, 2011, The Cochrane database of systematic reviews.

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

A. Paradiso, M. Mottolese, S. Pizzamiglio, 2013, Journal of experimental & clinical cancer research : CR.

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

N. Tinari, G. Ciliberto, L. Mariani, 2019, Therapeutic advances in medical oncology.

Quality of life and disability of chronic non-cancer pain in adults patients attending pain clinics: A prospective, multicenter, observational study.

L. Bertini, G. Varrassi, G. Esposito, 2020, Applied nursing research : ANR.

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer

G. Ciliberto, E. Gallo, B. Casini, 2018, Journal of translational medicine.

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

G. Ciliberto, E. Gallo, B. Casini, 2018, Journal of Translational Medicine.

Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy

Francesca Sperati, Gennaro Ciliberto, Matteo Pallocca, 2019, Journal of Translational Medicine.

Erratum to: Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life

P. Muti, M. Maschio, L. Dinapoli, 2012, Journal of Neuro-Oncology.

Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study

M. Maschio, L. Dinapoli, A. Fabi, 2012, Epileptic disorders : international epilepsy journal with videotape.

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

E. Pescarmona, A. Sapino, M. Mottolese, 2017, Journal of experimental & clinical cancer research : CR.

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Lara A. Kahale, E. Akl, H. Schünemann, 2014, The Cochrane database of systematic reviews.

The efficacy of injecting hybrid cooperative complexes of hyaluronic acid for the treatment of vulvar lichen sclerosus: A preliminary study

F. Sperati, A. Morrone, V. Garelli, 2022, Dermatologic therapy.

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

G. Sanguineti, A. Giordano, P. Marchetti, 2017, Scientific Reports.

Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study

G. Ciliberto, R. Biagini, V. Ferraresi, 2023, Frontiers in Psychology.

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression

G. Ciliberto, V. Speirs, I. Vitale, 2017, Scientific Reports.

EPIDEMIOLOGY, GENETICS AND PATHOGENESIS A01 FAMILIAL MELANOMA AND MULTIPLE PRIMARY MELANOMA: ANALYSIS OF PREDISPOSING GENETIC MUTATIONS IN 190 PATIENTS

Madonna, D., G., 2021 .

p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.

E. Pescarmona, M. Mottolese, F. Cognetti, 2020, Clinical breast cancer.

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

M. Mottolese, I. Terrenato, F. Sperati, 2016, Journal of Experimental & Clinical Cancer Research.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

E. Akl, H. Schünemann, P. Muti, 2008, The Cochrane database of systematic reviews.

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

R. Maria, M. Mottolese, A. Pagliuca, 2014, Oncotarget.

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

I. Vitale, M. Mottolese, A. Fabi, 2015, Oncotarget.

Thromboprophylaxis for patients with cancer and central venous catheters

D. Cook, E. Akl, H. Schünemann, 2008, Cancer.

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Lara A. Kahale, E. Akl, H. Schünemann, 2017, The Cochrane database of systematic reviews.

Diagnostic Accuracy of Contrast-Enhanced, Spectral Mammography (CESM) and 3T Magnetic Resonance Compared to Full-Field Digital Mammography plus Ultrasound in Breast Lesions: Results of a (Pilot) Open-Label, Single-Centre Prospective Study

I. Terrenato, F. Sperati, P. Vici, 2022, Cancers.

Framing of health information messages.

E. Akl, A. Oxman, H. Schünemann, 2011, The Cochrane database of systematic reviews.

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world

L. Landi, G. Minuti, E. Pescarmona, 2023, Journal of Translational Medicine.

Multiple Brain Metastases Radiosurgery with CyberKnife Device: Dosimetric Comparison between Fixed/Iris and Multileaf Collimator Plans

E. Infusino, L. Marucci, F. Sperati, 2023, Journal of medical physics.

Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.

D. Cook, E. Akl, H. Schünemann, 2008, Archives of internal medicine.